Compliance With Continuous Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea Syndrome (CPAPSH)
Evaluation of Compliance With CPAP Therapy in Patients Diagnosed With Obstructive Sleep Apnea Syndrome at the Hospital de Sabadell
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Montserrat Montaña, PhD
- Phone Number: +34692617376
- Email: mmontana@tauli.cat
Study Contact Backup
- Name: Maria José Masdeu, MD
- Phone Number: 21191 +34937231010
- Email: mjmasdeu@tauli.cat
Study Locations
-
-
Barcelona
-
Sabadell, Barcelona, Spain, 08208
- Recruiting
- CorporacionPT
-
Contact:
- Montserrat Montaña, PhD
- Phone Number: +34692617376
- Email: mmontana@tauli.cat
-
Contact:
- Maria José Masdeu, MD
- Phone Number: 21191 +34937231010
- Email: mjmasdeu@tauli.cat
-
Principal Investigator:
- Montserrat Montaña, PhD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients over 18 years of age treated with CPAP based on the diagnosis of OSAS (clinical picture and AHI> 10).
Exclusion Criteria:
- Diagnosis of a psychiatric illness or dementia.
- Communication problems or inability to read and speak Spanish.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Patients SAHS with CPAP
Continuous Positive Airway Pressure treatment
|
CPAP indication
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence rate to CPAP treatment
Time Frame: 1 year after starting treatment
|
% of patients who still use CPAP
|
1 year after starting treatment
|
|
Ratio of patients with compliance with the treatment
Time Frame: 1 year after starting treatment
|
% of patients use CPAP ≥4h / night
|
1 year after starting treatment
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Montserrat Montaña, PHD, Corporacion Parc Tauli
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2018569
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.